Nuwellis (NUWE) News Today $1.18 -0.02 (-1.67%) As of 01/3/2025 05:39 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period FDA issues “high-risk” safety alert to Nuwellis blood circuit setsDecember 31, 2024 | finance.yahoo.comFDA says aware Nuwellis recalling certain blood circuit lotsDecember 30, 2024 | markets.businessinsider.comNuwellis regains Nasdaq compliance with bid and equity rulesDecember 21, 2024 | uk.investing.comNuwellis, Inc. Regains Compliance with Nasdaq's Minimum Bid Price and Equity RequirementsDecember 21, 2024 | nasdaq.comNuwellis, Inc.: Nuwellis Regains Compliance with Nasdaq Listing RequirementsDecember 19, 2024 | finanznachrichten.deNuwellis Regains Compliance with Nasdaq Listing RequirementsDecember 19, 2024 | globenewswire.comNuwellis files to sell 3.73M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comQ3 2024 Nuwellis Inc Earnings CallNovember 12, 2024 | finance.yahoo.comNuwellis, Inc. (NASDAQ:NUWE) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comNuwellis, Inc. (NUWE) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comNuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent HighlightsNovember 11, 2024 | globenewswire.comExamining the Future: Nuwellis's Earnings OutlookNovember 9, 2024 | benzinga.comNuwellis announces exercise of warrants for $5.1M in gross proceedsNovember 6, 2024 | markets.businessinsider.comNuwellis tumbles on exercise of warrants to raise $5.1MNovember 6, 2024 | msn.comNuwellis Announces Exercise of Warrants for $5.1 Million of Gross ProceedsNovember 5, 2024 | globenewswire.comNuwellis Stock Spikes After Reimbursement Hike: Retail’s UpbeatNovember 5, 2024 | msn.comNuwellis receives increased reimbursement rate for Aquadex SmartFlow therapyNovember 4, 2024 | markets.businessinsider.comNuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex SystemNovember 4, 2024 | finance.yahoo.comNuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and MedicaidNovember 4, 2024 | globenewswire.comNuwellis Shares Surge Following Preliminary 3Q ResultsNovember 1, 2024 | marketwatch.comNuwellis Announces Preliminary Results for Third Quarter of 2024November 1, 2024 | globenewswire.comNuwellis announces University of Iowa Health Care as newest customerOctober 31, 2024 | markets.businessinsider.comNuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric CustomerOctober 31, 2024 | markets.businessinsider.comNuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric CustomerOctober 31, 2024 | globenewswire.comSeastar Medical settles dispute with Nuwellis for $900KOctober 24, 2024 | investing.comNuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024October 23, 2024 | globenewswire.comNuwellis to Present at the Third Annual ROTH Healthcare Opportunities ConferenceSeptember 25, 2024 | globenewswire.comRoth MKM Keeps Their Buy Rating on Zevra Therapeutics (ZVRA)September 24, 2024 | markets.businessinsider.comNuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq RulesAugust 23, 2024 | globenewswire.comNUWE Stock Earnings: Nuwellis Beats EPS, Beats Revenue for Q2 2024August 14, 2024 | msn.comNuwellis, Inc. (NASDAQ:NUWE) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comNuwellis, Inc. Announces Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comNuwellis Q2 Earnings PreviewAugust 12, 2024 | msn.comNuwellis earnings preview: what to expectAugust 12, 2024 | markets.businessinsider.comNasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to ConditionsAugust 8, 2024 | finance.yahoo.comRoth MKM Initiates Coverage of Nuwellis (NUWE) with Buy RecommendationJuly 30, 2024 | msn.comWhy Nuwellis Stock Is ClimbingJuly 30, 2024 | msn.comCatalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earningsJuly 27, 2024 | msn.comNuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’sJuly 26, 2024 | finance.yahoo.comNuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children'sJuly 26, 2024 | globenewswire.comNuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq RulesJuly 24, 2024 | markets.businessinsider.comNuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq RulesJuly 24, 2024 | globenewswire.comNuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024July 23, 2024 | globenewswire.comNuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’sJuly 19, 2024 | markets.businessinsider.comNuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children'sJuly 17, 2024 | globenewswire.comNuwellis Announces Reverse Stock SplitJune 26, 2024 | globenewswire.comNuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™June 25, 2024 | globenewswire.comDaVita, Nuwellis Extend Pilot Collaboration for AquadexJune 11, 2024 | benzinga.comNuwellis and DaVita Extend Supply and Collaboration Agreement Pilot PhaseJune 6, 2024 | globenewswire.comNuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaMay 14, 2024 | finance.yahoo.com Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address NUWE Media Mentions By Week NUWE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUWE News Sentiment▼0.870.87▲Average Medical News Sentiment NUWE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUWE Articles This Week▼21▲NUWE Articles Average Week Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NRXS News LFWD News NEPH News PYPD News LYRA News IINN News SSKN News LUCY News PETV News AEMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUWE) was last updated on 1/6/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia second company to cross $3.5 trillion. It’s just the startNvidia has moved on to the next frontier of AI it intends to dominate. And we believe the three companies p...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.